Delivering excellence in ophthalmic clinical trials
Cerulea Clinical Trials is dedicated to delivering excellence in ophthalmic clinical trials, supporting both Australian and international biopharmaceutical and medtech companies. Located at 32 Gisborne St, Level 7, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria 3002, AU, Cerulea Clinical Trials also facilitates investigator-initiated studies for the Centre for Eye Research Australia (CERA).
As a fully owned, not-for-profit subsidiary of CERA, Cerulea Clinical Trials shares a commitment to a world free from vision loss and blindness. The organization focuses on advancing clinical research, clinical development, and the application of medical devices and gene therapy within the field of ophthalmology. Cerulea Clinical Trials plays a crucial role in driving innovation and progress in the biopharmaceutical and biotechnology sectors.
Cerulea Clinical Trials continues to expand its capabilities and impact within the biotechnology research landscape. The team at Cerulea Clinical Trials is focused on fostering advancements in eye research and delivering meaningful outcomes. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further highlight their expertise and services.
Cerulea Clinical Trials se consacre à fournir l'excellence dans les essais cliniques ophtalmiques, en soutenant les sociétés biopharmaceutiques et de technologies médicales australiennes et internationales. Situé au 32 Gisborne St, Level 7, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria 3002, AU, Cerulea Clinical Trials facilite également les études initiées par des chercheurs pour le Centre for Eye Research Australia (CERA).
En tant que filiale à part entière et à but non lucratif de CERA, Cerulea Clinical Trials partage un engagement envers un monde sans perte de vision ni cécité. L'organisation se concentre sur l'avancement de la recherche clinique, du développement clinique et de l'application des dispositifs médicaux et de la thérapie génique dans le domaine de l'ophtalmologie. Cerulea Clinical Trials joue un rôle crucial dans la promotion de l'innovation et des progrès dans les secteurs biopharmaceutiques et biotechnologiques.
Cerulea Clinical Trials continue d'étendre ses capacités et son impact dans le paysage de la recherche en biotechnologie. L'équipe de Cerulea Clinical Trials se concentre sur la promotion des progrès dans la recherche sur les yeux et la fourniture de résultats significatifs. Nous invitons l'équipe de direction à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre en évidence davantage leur expertise et leurs services.
Compare Cerulea Clinical Trials with 3 companies in Biotechnology-Research
| Comparison Field |
Cerulea Clinical TrialsMain Company |
Cl
ClinipaceView Profile |
AL SolutionsView Profile |
Sling TherapeuticsView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2003 | 2018 | |
|
Company Size
|
— | 501-1,000 | 51-200 | 2-10 |
|
City
|
East Melbourne, Victoria | Morrisville, North Carolina | London, Greater London | Ann Arbor, MI |
|
Country
|
Australia | United States | United Kingdom | United States |
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Ophthalmic Clinical Trials
Biopharmaceutical Research
Medtech
Clinical Research
Gene Therapy
Ophthalmology
Biotechnology
Clinical Trials
Clinical research
clinical development
medical devices
gene therapy
medical research
biopharma pharmaceuticals
biotechnology
|
9 Total
9 Unique
Unique Skills:
clinical trials
contract research organization
CRO
data management
drug development
medical device development
+3
|
24 Total
24 Unique
Unique Skills:
biometrics
clinialoperations
clinical monitoring
clinical operations
clinical trials
clinicaldevelopment
+18
|
17 Total
17 Unique
Unique Skills:
Autoimmune
chemistry
clinical research
clinical study
drug development
Endocrinology
+11
|
Other organizations in the same industry
This company is also known as